Evidence for two phenotypes in the metabolism of methotrexate to 7-hydroxymethotrexate in patients with rheumatoid arthritis

Arthritis and Rheumatism

Volumn 52, Issue 1, 2005, Pages 356-358

  Baggott, Joseph E ^a   Bridges Jr , S Louis ^a   Morgan, Sarah L ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 HYDROXYMETHOTREXATE; ALDEHYDE OXIDASE; BENZALDEHYDE; METHOTREXATE; N METHYLNICOTINAMIDE; POLYGLUTAMIC ACID;

ARTICLE; CHI SQUARE DISTRIBUTION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG METABOLISM; DRUG URINE LEVEL; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LEUKEMIA; MICHAELIS CONSTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; URINARY EXCRETION;

ARTHRITIS, RHEUMATOID; HUMANS; METHOTREXATE; PHENOTYPE; TIME FACTORS;

EID: 12344279813     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20742     Document Type: Article

References (14)

1. Fox RI, Morgan SL, Smith HT, Robbins BA, Choc MG, Baggott JE. Combined oral cyclosporin and methotrexate therapy in patients with rheumatoid arthritis elevates methotrexate levels and reduces 7-hydroxymethotrexate levels when compared with methotrexate alone. Rheumatology (Oxford) 2003;42:989-94.
2. Johns DG, Iannotti AT, Sartorelli AC, Booth BA, Bertino JR. Enzymic oxidation of methotrexate and aminopterin. Life Sci 1964;74:1383-8.
3. Fabre G, Seither R, Goldman ID. Hydroxylation of 4-amino-antifolates by partially purified aldehyde oxidase from rabbit liver. Biochem Pharmacol 1986;35:1325-30.
4. Beedham C, Critchley DJ, Rance DJ. Substrate specificity of human liver aldehyde oxidase toward substituted quinazolines and phthalazines: a comparison with hepatic enzyme from guinea pig, rabbit, and baboon. Arch Biochem Biophys 1995;319:481-90.
5. Terao M, Kurosaki M, Demontis S, Zanotta S, Garattini E. Isolation and characterization of the human aldehyde oxidase gene: conservation of intron/exon boundaries with the xanthine oxidoreductase gene indicates a common origin. Biochem J 1998;332:383-93.
6. Pollard JH. A handbook of numerical and statistical techniques with examples mainly from the life sciences. Cambridge: Cambridge University Press; 1977.
7. Seideman P, Beck O, Eksborg S, Wennberg M. The pharmacokinetics of methotrexate and its 7-hydroxy metabolite in patients with rheumatoid arthritis. Br J Clin Pharmacol 1993;35:409-12.
8. Chladek J, Martinkova J, Simkova M, Vaneckova J, Koudelkova V, Nozickova M. Pharmacokinetics of low doses of methotrexate in patients with psoriasis over the early period of treatment. Eur J Clin Pharmacol 1998;53:437-44.
9. Chladek J, Grim J, Martinkova K, Simkova M, Vaniekova J, Koudelkova V, et al. Pharmacokinetics and pharmacodynamics of low-dose methotrexate in the treatment of psoriasis. Br J Clin Pharmacol 2002;54:147-56.
10. Sonneveld P, Schultz FW, Nooter K, Hahlen K. Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in plasma and bone marrow of children receiving low-dose oral methotrexate. Cancer Chemother Pharmacol 1986;18:111-6.
11. Rodrigues AD. Comparison of levels of aldehyde oxidase with cytochrome P450 activities in human liver in vitro. Biochem Pharmacol 1994;48:197-200.
12. Sugihara K, Kitamura S, Tatsumi K, Asahara T, Dohi K. Differences in aldehyde oxidase activity in cytosolic preparations of human and monkey liver. Biochem Mol Biol Int 1997;41:1153-60.
13. Al-Salmy HS. Individual variation in hepatic aldehyde oxidase activity. IUBMB Life 2001;51:249-53.
14. Baggott JE, Morgan SL, Koopman WJ. The effect of methotrexate and 7-hydroxymethotrexate on rat adjuvant arthritis and on urinary aminoimidazole carboxamide excretion. Arthritis Rheum 1998;41:1407-10.